Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 4Completed 4Terminated 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1CNS 1Breast 1

Conditions

Melanoma 1Lymphoma, T-Cell, Peripheral 1Hodgkin Disease 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Salvage Therapy × Clear all
NCT07470996 2026-03-13

T-START-NR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
58 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting
218 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT05933733 2025-06-29

SALT-LRR

Samsung Medical Center

Recruiting
190 enrolled
Breast

Breast Neoplasms

NCT04378647 2024-02-26

BRESELIBET

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Phase 2 Recruiting
150 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡